4th Quarter - Report
THE RABEN GROUP for AMGEN U.S.A. INC
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Lobbying in Support of HR 1548 the Pathways for Biologics Act, to promote patient safety while supporting the development of biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LICY DO CANTO | — |
| LAWRENCE FRANCISCO GONZALEZ | — |
| ROBERT RABEN | Asst. Attorney Gen, DOJ; Counsel House Judiciary |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.